Cervical cancer screening by molecular Pap ‐transformation of gynecologic cytology
ConclusionLBC with HPV cotesting improves sensitivity and specificity and reduces ambiguous results; allows better compliance, as a negative result of both tests allows patients to get screening every 5 years, thereby increasing screening intervals, important in a resource limited situation.
Source: Diagnostic Cytopathology - Category: Pathology Authors: Shaikhali M Barodawala,
Kirti Chadha,
Vikas Kavishwar,
Anuradha Murthy,
Shamma Shetye Tags: ORIGINAL ARTICLE Source Type: research
More News: Cancer | Cancer & Oncology | Cervical Cancer | Cytology | India Health | Laboratory Medicine | Papanicolaou (Pap) Smear | Study | Women